News and Trends 18 Aug 2022
Patients with beta-thalassemia able to access first approved gene therapy
A gene therapy drug approved by the U.S. Food and Drug Administration (FDA) has been made accessible for people with…
Bluebird Bio
- Latest Posts
In Depth 11 Oct 2021
A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this ‘miraculous technology’ and what can…
News and Trends 4 May 2021
Bluebird Bio Withdrawal Raises Gene Therapy Doubts in Europe
Last month, the US firm bluebird bio abandoned the sale of its gene therapy Zynteglo in Germany after a pricing…
News and Trends 14 Jan 2020
Bluebird Bio Launches First Gene Therapy for Beta Thalassemia in Germany
The US company bluebird bio has launched the first gene therapy for the blood disorder transfusion-dependent beta thalassemia in the…
ADVERTISEMENT
More News! 9 Oct 2019
Novo Nordisk and Bluebird Bio to Treat Hemophilia with Gene Editing
The Danish big pharma Novo Nordisk has joined forces with the US gene therapy company bluebird bio to develop next-generation…
News and Trends 14 Jun 2019
First Gene Therapy for Beta Thalassemia Will Cost Over €1.5M
Zynteglo, a gene therapy developed by the US company bluebird bio for the treatment of beta-thalassemia, will cost European healthcare…
News and Trends 4 Jun 2019
First Gene Therapy for Beta Thalassemia Approved in Europe
The US biotech company bluebird bio has obtained EU conditional market approval for a gene therapy that could remove the…
News and Trends 20 Apr 2018
Gene Therapy For Beta-Thalassemia Could Eliminate Need for Transfusions
Bluebird bio has obtained results from two clinical studies showing its new gene therapy could eliminate the need for red blood…
News and Trends 7 Dec 2017
Scottish Biotech and Bluebird Bio to Develop Next Generation CAR-T Cells
TC Biopharm has scored a deal with bluebird bio for the development of the next generation of CAR-T cells, a…
News and Trends 26 Dec 2016
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
Curious about which technologies have attracted the most cash in biotech finance this year? Here's a list of the most impressive cash…
News and Trends 14 Dec 2016
What do the CAR-T Patient Deaths Mean for the Future of the Field?
Juno’s JCAR015 study came to a halt for the second time this year after two more patient deaths. But despite…
News and Trends 22 Sep 2015
UniQure’s cure for rare Lysosomal disease ready for phase III trial
UniQure from the Netherlands has promising results for its enzyme replacement therapy phase Ib/II trial targeting a rare Lysosomal disease.…
News and Trends 18 Jun 2015
German Viral Vector Producer SIRION pursues its American dream and opens in Boston
The biggest biocluster of the World is still attractive. Munich-based Sirion Biotech decided to open an office to establish its…
News and Trends 8 May 2015
GSK sparks off the Gene Therapy resurgence
GlaxoSmithKline has become the first big pharma company to file a gene therapy approval case to the European Medicines Agency (EMA). The…
News and Trends 10 Mar 2015
Live from Bio-Europe 2015: The product development challenges in the gene therapy field
Gene Therapy is really the hot topic right now in the field of Biotech especially with technologies such as CRISPR and…
News and Trends 5 Dec 2014
Forbion Capital Partners: a Leading European Biotech VC is rising!
Forbion Capital Partners, the leading Dutch Venture Capital firm investing in world-class healthcare technologies, sold PneumRx of its portfolio, to BTG plc,…
ADVERTISEMENT
News and Trends 1 Dec 2014
The First Gene Therapy Drug Will Be Sold at Record €1,1M Price
What could you buy with €1,1M euros? A house? Or a single prescription for a new drug... The first gene therapy drug…
News and Trends 17 Oct 2014
Should European Biotech CEOs wear more sneakers?
Today is Friday or Casual Day. Did you leave the suit and the tie at home to wear jeans and sneakers? Should…
